Navigation Links
Silicon Biosystems Appoints Farideh Bischoff, Ph.D. as Executive Director of Scientific Affairs

San Diego, CA (PRWEB) September 24, 2014

Silicon Biosystems, Inc. announced the appointment of Farideh Bischoff, Ph.D. as Executive Director of Scientific Affairs. Dr. Bischoff has more than 20 years of experience in reproductive genetics and cancer research and diagnostics. Prior to joining Silicon Biosystems, Dr. Bischoff served as Vice President of Translational Research and Clinical Development at Biocept, Inc. where she was responsible for overseeing clinical studies, assay development for commercialization and CLIA validation, and academic collaborations. At Silicon Biosystems she is expected to have responsibility for all scientific collaborations and helping to define and drive the clinical strategy for the company.

“We are extremely happy to have Dr. Bischoff join our company,” said Robert Proulx, President of Silicon Biosystems, Inc. “Farideh brings an extraordinary depth of experience and working knowledge of the science in two key areas where our technology applies. Her recent work in developing a CLIA certified test for metastatic breast cancer based on CTCs and the relationships she has within the cancer research and diagnostics community will directly impact current business. Additionally, her background in reproductive genetics will be beneficial as we pursue other markets where our DEPArray technology has value, such as prenatal genetic testing.”

“I am extremely excited to join Silicon Biosystems, Inc.” said Dr. Bischoff. “Silicon Biosystems’ innovative and state of the art DEPArray platform enables isolation of pure rare cell populations and I’m thrilled to be leading the team in developing strategies that will enable highly sensitive downstream molecular diagnostics."

About Silicon Biosystems
Silicon Biosystems, S.p.A., a wholly owned and operated subsidiary of The Menarini Group, manufactures and sells the DEPArray platform which is based on the principle of dielectrophoresis to isolate and manipulate cells in suspension with a microelectronic array. The approach, patented by Silicon Biosystems, offers the unique ability to control individual cells and micro-particles inside a disposable cartridge. The DEPArray platform makes it possible to find, sort, select, and separate individual cells for further analysis or culturing. For more information on Silicon Biosystems, visit

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Applied Silicone Launches Silicone Gel System with Dual Matrix Technology
2. Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley
3. SURPASS Announces Two Strategic Hires in Silicon Valley Facility and Launch of Social Media Accounts
4. Silicon sponge improves lithium-ion battery performance
5. Applied Silicone Launches Ultra-Soft LSR
6. In-depth Research on China Organic Silicon Industry, 2013-2017 (Update Version)
7. Amedica Signs Agreement with Kyocera for Commercial Manufacture of Silicon Nitride Medical Devices
8. Stanford scientists create a low-cost, long-lasting water splitter made of silicon and nickel
9. New device stores electricity on silicon chips
10. NIST/JQI team gets the edge on photon transport in silicon
11. Brainwave Signal Interpretation Software Company EyeMynd Announces Move to Silicon Valley
Post Your Comments:
(Date:5/14/2020)... ... May 13, 2020 , ... Early stages of drug ... or no information on the drug’s mechanism of action (MOA). Gene expression profiling ... measuring the activity of molecular pathways. This information can complement phenotypic readouts and ...
(Date:5/5/2020)... ... 04, 2020 , ... Red Nucleus, a leading provider of ... that Informa Training Partners, a life sciences training company acquired by Red Nucleus ... immediately. , “The name change solidifies a stronger presence for Red Nucleus in ...
(Date:5/5/2020)... TAMPA, Fla. (PRWEB) , ... May 05, 2020 ... ... technology and solutions company, announced today the launch of its iGlucose® ... The new iGlucose solution utilizes LTE Cat-M1 technology, the industry’s newest and broadest ...
(Date:4/26/2020)... ... April 23, 2020 , ... Indegene Omnipresence, ... store providing applications and services for use on Microsoft Azure. The customer experience ... sign up online for a built-for-purpose customer engagement capability to use in their ...
Breaking Biology Technology:
(Date:5/14/2020)... , ... May 14, 2020 , ... ... board for medical sales representatives, found the 2019 average medical sales rep total ... risk being shadowed by uncertainties amid the COVID-19 global crisis. , The MedReps ...
(Date:5/1/2020)... Colo. (PRWEB) , ... April 30, 2020 , ... ... insights, today announced an alliance with Corritori Consulting Inc., a biopharmaceutical and regulatory ... the pharmaceutical and companion diagnostics industries. Flagship and Corritori are taking a collaborative ...
(Date:4/30/2020)... ... 2020 , ... At the start of 2020 ILC ... a wide range of industries including pharmaceutical and biopharmaceutical manufacturing, healthcare, food and ... decade, it was clear to company leadership that they would have to adapt ...
Breaking Biology News(10 mins):